Twin Health Secures $53M, Nears $1B Valuation for AI Metabolic Platform

Twin Health, a California-based company developing AI-enabled digital twin technology to improve metabolic health, has raised $53 million in a Series E funding round led by Denmark's Maj Invest, boosting its valuation to $950 million. The company's platform creates personalized AI models of individuals' metabolisms using data from wearable devices, lab tests, and self-reporting, providing continuous, 24/7 guidance on nutrition, sleep, activity, and stress to help prevent and reverse metabolic diseases like type 2 diabetes and obesity. A clinical trial published in the New England Journal of Medicine Catalyst demonstrated that Twin Health's system helped 71% of type 2 diabetes patients reach target A1C levels, with many able to reduce or eliminate costly medications such as GLP-1 agonists. Twin Health partners with employers and health plans, offering a performance-based pricing model that ties costs to achieved clinical outcomes. The new funding will support expansion among health plans and Fortune 500 clients across multiple sectors and aims to bring the company to profitability by next year. CEO Jahangir Mohammed emphasized that their approach addresses root causes of metabolic disease through personalized care rather than episodic treatment, contrasting with traditional medication-focused strategies.